The Development of a Domestic Violence Perpetrator Collusion Measurement Tool

August 29, 2023 updated by: Yale University

Media, Public Health, and Colluding With Murder: The Development of a Domestic Violence Perpetrator Collusion Measurement Tool.

We propose an experimental design to empirically establish the potential link between the media portrayal of DV and changes in an individual's DV descriptive and injunctive social norms. Specifically, this study will measure the degree to which people implicitly collude with DV perpetration.

Study Overview

Detailed Description

Aim 1: To determine the impact of media "frames," "labeling," and "information inclusion" on "implicit collusion" with a DV perpetrator.

Hypotheses: Consumers exposed to media reports using "thematic frames" will be less likely to implicitly collude with perpetrators than those exposed to "episodic frames." Consumers exposed to DVH news stories labeled as "domestic violence" will be less likely to implicitly collude with perpetrators than consumers exposed to news stories labeled as "assault." Implicit collusion will correlate positively with the addition of non-relevant perpetrator "humanizing" characteristics. Consumers given negative information about the victim of DVH will be more likely to implicitly collude with the perpetrator than consumers given negative information about the perpetrator.

Aim 2: To determine how media portrayals of domestic violence impact descriptive and injunctive norms about domestic violence and, ultimately, drive implicit collusion with perpetrators.

Hypotheses: Controlling for individual pre-existing attitudes and social norms, consumers exposed to thematic frames or the label of DV will be less likely to shift their norms in a way that supports DV than those exposed to episodic frames or the label of assault. Consumers provided negative victim information or non-relevant characteristics that humanize the perpetrator will be more likely to shift their norms to accept DV.

Exploratory Aim: To identify racial/ethnic, gender, age, and regional differences in DV social norms.

Hypothesis: The media will differentially impact subpopulation DV attitudes, social norms and implicit collusion.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06519
        • Yale University
    • Louisiana
      • New Orleans, Louisiana, United States, 70118
        • Loyola University New Orleans
    • Michigan
      • East Lansing, Michigan, United States, 48824
        • Michigan State University
      • Lansing, Michigan, United States, 48913
        • Michigan Department of Community Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Members of the public who are 18 years or older, who identify as White or African American or Hispanic.

Exclusion Criteria:

  • Members of the public will be excluded if they are unable to read or understand English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Condition 1

Each study arm contains different scenarios presented to the participant.

Condition 1 is a Perpetrator Positive scenario.

The content of the Condition 1 group is as follows:

Framing: Episodic Labeling: DV label Extraneous Information: Perpetrator positive non relevant Victim/Perp Characteristic: Negative victim

Condition 1 frames the event as episodic, labels the event as domestic violence, uses a positive description of the perpetrator, and a negative description of the victim.
Experimental: Condition 2

Each study arm contains different scenarios presented to the participant.

Condition 2 is a Perpetrator Negative scenario.

The content of the Condition 2 group is as follows:

Framing: Thematic Labeling: Assault label Extraneous Information: Perpetrator neutral non relevant Victim/Perp Characteristic: Negative Perpetrator

The condition 2 intervention/exposure frames the event as thematic, labels the event as assault, uses a neutral description of the perpetrator, and a negative description of the perpetrator.
Placebo Comparator: Condition 3

Each study arm contains different scenarios presented to the participant.

The content of the Condition 3 group is as follows:

Framing: Neither Labeling: No label Extraneous Information: None Victim/Perp Characteristic: None

This intervention provides no details for the participant and is for comparison use in the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline on The Collusion Framing Subscale
Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
The scale will be developed based on the changes from baseline.
The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
Change from Baseline on The Collusion Labeling Subscale
Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
The scale will be developed based on the changes from baseline.
The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
Change from Baseline on The Collusion Extraneous Information Subscale
Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
The scale will be developed based on the changes from baseline.
The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
Change from Baseline on The Collusion Negative Characteristics Subscale
Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
The scale will be developed based on the changes from baseline.
The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2009

Primary Completion (Actual)

January 1, 2010

Study Completion (Actual)

January 1, 2010

Study Registration Dates

First Submitted

August 30, 2013

First Submitted That Met QC Criteria

September 10, 2013

First Posted (Estimated)

September 16, 2013

Study Record Updates

Last Update Posted (Actual)

August 30, 2023

Last Update Submitted That Met QC Criteria

August 29, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 0910005885

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intimate Partner Violence (IPV)

Clinical Trials on Condition 1: Perpetrator Positive

3
Subscribe